English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Orexigen Therapeutics

Nicholas Gueguen | Aug 13, 2017

Orexigen Therapeutics teams with Cheplapharm Arzneimittel GmbH to put Mysimba on German, Austrian and French markets

Ruth de Jauregui | Apr 9, 2017

Bruno Farmaceutici, Orexigen Therapeutics Ireland to distribute Mysimba in Italy

Keri Carbaugh | Dec 28, 2016

Orexigen Therapeutics enters distribution agreement with Biologix for Contrave

Trending

+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'

+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily